Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-09-11 | Dr. Joseph Keegan serves as director and advisor... Board believes Dr. Keegan is qualified... Member of Audit Committee. Director Compensation Table shows total $227,259. |
| 2019-09-09 | Joseph D. Keegan, Ph.D. Age: 66 Independent Director Since: 2017 Other Public Directorships: Interpace Diagnostics Dr. Keegan brings important life science background to the Board through his career working at a number of life sciences companies, with a focus on diagnostics. His knowledge of the Company's customers and products is especially valuable. Dr. Keegan further offers extensive executive management experience and board level experience through his past and present service on other private and public company boards. Director Compensation for FY 2019 Joseph Keegan, Ph.D. Total: $252,427 |
| 2020-09-15 | Joseph D. Keegan, Ph.D. Age: 67 Independent Director Since: 2017 Member of Executive Compensation Committee Director Compensation for FY 2020: $273,759 |
| 2024-09-12 | Joseph D. Keegan, Ph.D. Age: 71 Director since: 2017 INDEPENDENT Committees: Compensation Nominations & Governance ...Dr. Keegan brings an important life science background to the Board from his career working at a number of life sciences companies, with a focus on diagnostics. ...Compensation Paid to the Non-Employee Directors Joseph Keegan, Ph.D. Fees Earned or Paid in Cash: $75,000 Stock Awards: $99,954 Option Awards: $100,010 All Other Compensation: $498 Total: $275,462 |
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-15 | Dr. Keegan earned a Ph.D. in Chemistry from Stanford University and a B.A. in Chemistry from Boston University. |
| 2012-07-20 | Dr. Keegan earned a Ph.D. in Physical Chemistry from Stanford University and a B.A. in Chemistry from Boston University. Dr. Keegan’s strong executive experience and knowledge of high growth life sciences businesses provides valuable support for general management matters and commercial adoption of our products. |
| 2013-04-26 | Dr. Keegan earned a Ph.D. in Physical Chemistry from Stanford University and a B.A. in Chemistry from Boston University. Dr. Keegan’s strong executive experience and knowledge of high growth life sciences businesses provides valuable support for general management matters and commercial adoption of our products. |
| 2014-04-28 | Dr. Keegan’s strong executive experience and knowledge of high growth life sciences businesses provides valuable support for general management matters and commercial adoption of our products. |
| 2015-04-17 | Dr. Keegan earned a Ph.D. in physical chemistry from Stanford University and has executive experience in life sciences companies. |
| 2016-04-14 | Dr. Keegan earned a Ph.D. in physical chemistry from Stanford University and a B.A. in chemistry from Boston University. Dr. Keegan’s strong executive experience and knowledge of high-growth life sciences businesses provides valuable support for general management matters and commercial adoption of our products. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22